SCHEMBL2809196

SCHEMBL2809196

CC/C(=C\Oc1ccc(OC)cc1)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.44
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
TAS1R3 Q7RTX0 2/20 0.42
TAS1R1 Q7RTX1 2/20 0.42
NR1I2 O75469 1/20 0.42
HTT P42858 1/20 0.41
KMT2A Q03164 2/20 0.41
GLA P06280 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
F2RL1 P55085 1/20 0.40
POLB P06746 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809198 1.00 GSK3B (0.44) GSK3BCA1CA2TAS1R3TAS1R1
SCHEMBL2811889 0.89 MAPT (0.41) HTTKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2811892 0.89 MAPT (0.41) HTTKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2813105 0.87 RECQL (0.40) KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2813106 0.87 RECQL (0.40) KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2808660 0.85 CA1 (0.44) GSK3BCA1CA2NR1I2NPC1
SCHEMBL2808659 0.85 CA1 (0.44) GSK3BCA1CA2NR1I2NPC1
SCHEMBL2807358 0.78 KMT2A (0.54) HTTKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2807360 0.78 KMT2A (0.54) HTTKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2808867 0.78 NFE2L2 (0.43) CA1CA2HTTKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 GSK3B 2418/4885CA1 1622/4885CA2 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.